课题基金 / 基金详情

RHUBARB AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR STUDY RACE II

RHUBARB AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR STUDY RACE II
大黄和血管紧张素转换酶抑制剂研究竞赛 II
批准号:
8167020
负责人:
John M. Burkart
金额:
$0.29万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-01 至 2011-02-28

项目摘要

项目成果

John M. Burkart的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Patients in China has suggested that rhubarb extract when used alone is equivalent to the protection afforded by ACEI. Furthermore when used in combination with ACEI, the renoprotective effect of rhubarb appears to be additive. Rhubarb extract is a chinese herbal preparation that is used extensively in china and other asian countries to treat constipation and CKD. Its mechanism of action in preventing progression of CKD is uncertain but perhaps related to TGF beta and TNF alph inhibition. The proposed study will be a prospective randomized double blinded placebo controlled study design to evaluate the efficacy of Rhubarb in addition to ACEI in proventing progression of CKD in adult patients with diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RHUBARB AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR STUDY (RACE) II
Rhubarb and ACE Inhibitor Study
Rhubarb and ACE Inhibitor Study
Rhubarb and ACE Inhibitor Study
海外基金